RDY FY 2018 Earnings Report — Dr. Reddy's Laboratories Limited Revenue & Financial Results | Market Cap Arena

Dr. Reddy's Laboratories LimitedRDY

FY 2018 Earnings

Reported June 15, 2018

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2018	Prior Q	FY 2017	QoQ Change	YoY Change
Revenue	$1.5B	—	$1.5B	—	0.9%
Op. Income	$127M	—	$143M	—	-11.7%
Gross Margin	53.7%	—	55.6%	—	-1.9pp
Net Margin	6.9%	—	8.5%	—	-1.6pp
EPS (Diluted)	$0.63	—	$0.77	—	-18.1%
Free Cash Flow	$74M	—	-$207M	—	135.9%

Revenue Flow

Item	Amount
REVENUE	$1.5B
Cost of Revenue	$698M
GROSS PROFIT	$810M
R&D Expenses	$194M
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$498M
Other Expenses	-$9M
Operating Expenses	$684M
Cost & Expenses	$1.4B
OPERATING INCOME	$127M
Interest Income	$6M
Interest Expense	$8M
Other Income/Expenses	$26M
INCOME BEFORE TAX	$152M
Income Tax Expense	$48M
Net Income from Continuing Ops	$104M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$104M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$104M
D&A	$124M
EBIT	$161M
EBITDA	$252M
EPS	$1
EPS Diluted	$1

Income Statement

Item	Amount
REVENUE	$1.5B
Cost of Revenue	$698M
GROSS PROFIT	$810M
R&D Expenses	$194M
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$498M
Other Expenses	-$9M
Operating Expenses	$684M
Cost & Expenses	$1.4B
OPERATING INCOME	$127M
Interest Income	$6M
Interest Expense	$8M
Other Income/Expenses	$26M
INCOME BEFORE TAX	$152M
Income Tax Expense	$48M
Net Income from Continuing Ops	$104M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$104M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$104M
D&A	$124M
EBIT	$161M
EBITDA	$252M
EPS	$1
EPS Diluted	$1

Cash Flow Statement

Item	Amount
Net Income	$104M
Depreciation & Amortization	$124M
Stock-Based Compensation	$5M
Deferred Income Tax	$48M
Other Non-Cash Items	$5M
Change in Working Capital	-$95M
OPERATING CASH FLOW	$191M
Capital Expenditure	-$117M
Acquisitions (Net)	$19M
Purchases of Investments	-$727M
Sales/Maturities of Investments	$680M
Other Investing Activities	-$13M
NET CASH FROM INVESTING	-$158M
Net Debt Issuance	$9M
Common Stock Repurchased	$0
Common Dividends Paid	-$42M
Other Financing Activities	-$14M
NET CASH FROM FINANCING	-$47M
FREE CASH FLOW	$74M
Net Change in Cash	-$13M

Balance Sheet

Item	Amount
Cash & Equivalents	$28M
Short-Term Investments	$195M
Net Receivables	$533M
Inventory	$309M
Other Current Assets	$193M
TOTAL CURRENT ASSETS	$1.2B
PP&E (Net)	$615M
Goodwill	$42M
Intangible Assets	$474M
Long-Term Investments	$49M
Tax Assets	$39M
Other Non-Current Assets	$13M
TOTAL NON-CURRENT ASSETS	$1.2B
TOTAL ASSETS	$2.4B
Account Payables	$98M
Short-Term Debt	$271M
Deferred Revenue	$10M
Other Current Liabilities	$117M
TOTAL CURRENT LIABILITIES	$740M
Long-Term Debt	$260M
Deferred Revenue NC	$29M
Deferred Tax Liabilities	$8M
Other Non-Current Liabilities	$46M
TOTAL NON-CURRENT LIABILITIES	$313M
TOTAL LIABILITIES	$1.1B
Common Stock	$9M
Additional Paid-In Capital	$83M
Retained Earnings	$1.2B
Treasury Stock	$0
Accum. Other Comp. Income	$42M
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$1.3B
Minority Interest	$0
TOTAL EQUITY	$1.3B
TOTAL LIABILITIES & EQUITY	$2.4B
Total Debt	$539M
Net Debt	$511M